MGM Cancer Institute Performs Complex Bone Marrow Transplant to Cure Rare Genetic Immunodeficiency in 33-Year-Old Woman

▴ MGM Cancer Institute
GATA2 primary immunodeficiency is an extremely rare genetic disorder, especially in adults, affecting immune cell production and putting patients at a high risk of developing serious blood cancers.

Chennai, 23rd July 2025: MGM Cancer Institute successfully performed a life-saving bone marrow transplant (BMT) on 33-year-old Ms. Janani, who was diagnosed with GATA2 primary immunodeficiency, a rare genetic disorder that weakens the immune system by impairing the production of essential blood and immune cells.

Bone marrow transplant (BMT) is the only definitive cure for GATA2 primary immunodeficiency, a condition that, if left untreated, can significantly increase the risk of developing serious bone marrow diseases such as myelodysplastic syndrome (MDS), a disorder in which the marrow produces poorly formed or dysfunctional blood cells or acute myeloid leukemia (AML), an aggressive cancer marked by the rapid growth of abnormal white blood cells in the blood and bone marrow.

Despite experiencing severe infection and gut-related complications during the transplant process, Ms. Janani responded well to intensive care, achieved timely engraftment, the point at which the newly transplanted stem cells begin producing healthy blood cells, and made a full recovery, returning to normal life just three months after the procedure.

In his comments, Dr. Gopinathan, Consultant, Hemato-Oncology, MGM Cancer Institute, who led the procedure, said, “This patient had been living with GATA2-related primary immunodeficiency for nearly 24 years, enduring recurrent infections throughout her life. Bone marrow transplantation is the only definitive cure for this condition, but achieving success requires a highly individualised approach, especially in complex cases. In her case, we performed a half-matched (haploidentical) transplant, where the donor shared only 50% of her genetic profile. Such procedures are technically demanding and require precise immune modulation to ensure successful engraftment and avoid serious complications. Adding to the complexity, she also had pulmonary alveolar proteinosis restricting her lung functions and disseminated non tubercular mycobacterial infection. These factors made the transplant significantly more challenging, particularly when it came to administering chemotherapy, which had to be carefully tailored due to her compromised lung function”.

In his comments, Dr. M.A. Raja, Director and Senior Consultant, Medical Oncology, MGM Cancer Institute, said, “GATA2 immunodeficiency is an exceptionally rare form of primary immunodeficiency, especially in adults, with only about 2% of cases presenting in adulthood. It is scarcely documented in medical literature and is known for its highly variable. Due to its progressive nature, early diagnosis is often difficult but critical. Research indicates that approximately 70% of individuals with GATA2 mutations eventually go on to develop myelodysplastic syndrome or acute myeloid leukemia. Therefore, bone marrow transplantation is crucial as a potential cure, and it reduces the long-term risk of malignant transformation.”

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Smart Operating Rooms: The Future of Hospital OTNovember 21, 2026
Smartphone Diagnostics: Phones as Medical Screening ToolsNovember 21, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026